{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T13:12:51Z","timestamp":1794834771923,"version":"4.9.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T00:00:00Z","timestamp":1679270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Moyamoya angiopathy (MMA) is a rare cerebrovascular condition leading to stroke. Mutations in 15 genes have been identified in Mendelian forms of MMA, but they explain only a very small proportion of cases. Our aim was to investigate the genetic basis of MMA in consanguineous patients having unaffected parents in order to identify genes involved in autosomal recessive MMA.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Exome sequencing (ES) was performed in 6 consecutive consanguineous probands having MMA of unknown etiology. Functional consequences of variants were assessed using western blot and protein 3D structure analyses.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Causative homozygous variants of <jats:italic>NOS3<\/jats:italic>, the gene encoding the endothelial nitric oxide synthase (eNOS), and <jats:italic>GUCY1A3<\/jats:italic>, the gene encoding the alpha1 subunit of the soluble guanylate cyclase (sGC) which is the major nitric oxide (NO) receptor in the vascular wall, were identified in 3 of the 6 probands. One <jats:italic>NOS3<\/jats:italic> variant (c.1502\u2009+\u20091G\u2009&gt;\u2009C) involves a splice donor site causing a premature termination codon and leads to a total lack of eNOS in endothelial progenitor cells of the affected proband. The other <jats:italic>NOS3<\/jats:italic> variant (c.1942\u00a0T\u2009&gt;\u2009C) is a missense variant located into the flavodoxine reductase domain; it is predicted to be destabilizing and shown to be associated with a reduction of eNOS expression. The <jats:italic>GUCY1A3<\/jats:italic> missense variant (c.1778G\u2009&gt;\u2009A), located in the catalytic domain of the sGC, is predicted to disrupt the tridimensional structure of this domain and to lead to a loss of function of the enzyme. Both <jats:italic>NOS3<\/jats:italic> mutated probands suffered from an infant-onset and severe MMA associated with posterior cerebral artery steno-occlusive lesions. The <jats:italic>GUCY1A3<\/jats:italic> mutated proband presented an adult-onset MMA associated with an early-onset arterial hypertension and a stenosis of the superior mesenteric artery. None of the 3 probands had achalasia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We show for the first time that biallelic loss of function variants in <jats:italic>NOS3<\/jats:italic> is responsible for MMA and that mutations in <jats:italic>NOS3<\/jats:italic> and <jats:italic>GUCY1A3<\/jats:italic> are causing fifty per cent of MMA in consanguineous patients. These data pinpoint the essential role of the NO pathway in MMA pathophysiology.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40246-023-00471-x","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:55:27Z","timestamp":1679864127000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Biallelic variants in NOS3 and GUCY1A3, the two major genes of the nitric oxide pathway, cause moyamoya cerebral angiopathy"],"prefix":"10.1186","volume":"17","author":[{"given":"St\u00e9phanie","family":"Guey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Herv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mano\u00eblle","family":"Kossorotoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaker","family":"Aloui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Bergametti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh","family":"Arnould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hind","family":"Guenou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Hadjadj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Dubois Teklali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Riant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Balligand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Uzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno O.","family":"Villoutreix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Tournier-Lasserve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,20]]},"reference":[{"issue":"12","key":"471_CR1","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","volume":"360","author":"RM Scott","year":"2009","unstructured":"Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226\u201337.","journal-title":"N Engl J Med"},{"issue":"5","key":"471_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2176\/nmc.52.295","volume":"52","author":"H Hoshino","year":"2012","unstructured":"Hoshino H, Izawa Y, Suzuki N. Research committee on moyamoya. Disease epidemiological features of moyamoya disease in Japan. Neurol Med Chir Tokyo. 2012;52(5):295\u20138.","journal-title":"Neurol Med Chir Tokyo."},{"issue":"8","key":"471_CR3","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/ejhg.2017.92","volume":"25","author":"S Guey","year":"2017","unstructured":"Guey S, Kraemer M, Herv\u00e9 D, Ludwig T, Kossorotoff M, Bergametti F, et al. Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians. Eur J Hum Genet EJHG. 2017;25(8):995\u20131003.","journal-title":"Eur J Hum Genet EJHG"},{"key":"471_CR4","first-page":"49","volume":"8","author":"S Guey","year":"2015","unstructured":"Guey S, Tournier-Lasserve E, Herv\u00e9 D, Kossorotoff M. Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet. 2015;8:49\u201368.","journal-title":"Appl Clin Genet"},{"issue":"3","key":"471_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.ajhg.2014.01.018","volume":"94","author":"D Herv\u00e9","year":"2014","unstructured":"Herv\u00e9 D, Philippi A, Belbouab R, Zerah M, Chabrier S, Collardeau-Frachon S, et al. Loss of \u03b11\u03b21 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia. Am J Hum Genet. 2014;94(3):385\u201394.","journal-title":"Am J Hum Genet"},{"key":"471_CR6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.scr.2017.04.009","volume":"21","author":"S Ferratge","year":"2017","unstructured":"Ferratge S, Ha G, Carpentier G, Arouche N, Bascetin R, Muller L, et al. Initial clonogenic potential of human endothelial progenitor cells is predictive of their further properties and establishes a functional hierarchy related to immaturity. Stem Cell Res. 2017;21:148\u201359.","journal-title":"Stem Cell Res"},{"issue":"7","key":"471_CR7","first-page":"1556","volume":"21","author":"M Lorenz","year":"2007","unstructured":"Lorenz M, Hewing B, Hui J, Zepp A, Baumann G, Bindereif A, et al. Alternative splicing in intron 13 of the human eNOS gene: a potential mechanism for regulating eNOS activity. FASEB J Off Publ Fed Am Soc Exp Biol. 2007;21(7):1556\u201364.","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol"},{"issue":"Pt 3","key":"471_CR8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1042\/bj3570593","volume":"357","author":"WK Alderton","year":"2001","unstructured":"Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J. 2001;357(Pt 3):593\u2013615.","journal-title":"Biochem J"},{"issue":"8","key":"471_CR9","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1073\/pnas.1400711111","volume":"111","author":"MG Campbell","year":"2014","unstructured":"Campbell MG, Underbakke ES, Potter CS, Carragher B, Marletta MA. Single-particle EM reveals the higher-order domain architecture of soluble guanylate cyclase. Proc Natl Acad Sci U S A. 2014;111(8):2960\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"471_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080635","volume":"8","author":"MZ Tien","year":"2013","unstructured":"Tien MZ, Meyer AG, Sydykova DK, Spielman SJ, Wilke CO. Maximum allowed solvent accessibilites of residues in proteins. PLoS ONE. 2013;8(11): e80635.","journal-title":"PLoS ONE"},{"issue":"4","key":"471_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/cge.12739","volume":"90","author":"S Wallace","year":"2016","unstructured":"Wallace S, Guo DC, Regalado E, Mellor-Crummey L, Bamshad M, Nickerson DA, et al. Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension. Clin Genet. 2016;90(4):351\u201360.","journal-title":"Clin Genet"},{"key":"471_CR12","doi-asserted-by":"crossref","unstructured":"F\u00f6rstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33(7):829\u201337, 837a\u2013837d.","DOI":"10.1093\/eurheartj\/ehr304"},{"issue":"2","key":"471_CR13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1161\/CIRCRESAHA.116.306531","volume":"119","author":"PM Vanhoutte","year":"2016","unstructured":"Vanhoutte PM, Zhao Y, Xu A, Leung SWS. Thirty years of saying NO: sources, fate, actions, and misfortunes of the endothelium-derived vasodilator mediator. Circ Res. 2016;119(2):375\u201396.","journal-title":"Circ Res"},{"issue":"6","key":"471_CR14","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00424-010-0867-4","volume":"460","author":"DN Atochin","year":"2010","unstructured":"Atochin DN, Huang PL. Endothelial nitric oxide synthase transgenic models of endothelial dysfunction. Pflugers Arch. 2010;460(6):965\u201374.","journal-title":"Pflugers Arch"},{"issue":"4","key":"471_CR15","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1172\/JCI1699","volume":"101","author":"RD Rudic","year":"1998","unstructured":"Rudic RD, Shesely EG, Maeda N, Smithies O, Segal SS, Sessa WC. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest. 1998;101(4):731\u20136.","journal-title":"J Clin Invest"},{"issue":"4","key":"471_CR16","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","volume":"118","author":"MA Gimbrone","year":"2016","unstructured":"Gimbrone MA, Garc\u00eda-Carde\u00f1a G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ Res. 2016;118(4):620\u201336.","journal-title":"Circ Res"},{"issue":"4","key":"471_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036386","volume":"7","author":"R Lin","year":"2012","unstructured":"Lin R, Xie Z, Zhang J, Xu H, Su H, Tan X, et al. Clinical and immunopathological features of Moyamoya disease. PLoS ONE. 2012;7(4): e36386.","journal-title":"PLoS ONE"},{"issue":"8","key":"471_CR18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI160227","volume":"132","author":"S Abdelilah-Seyfried","year":"2022","unstructured":"Abdelilah-Seyfried S, Iruela-Arispe ML, Penninger JM, Tournier-Lasserve E, Vikkula M, Cleaver O. Recalibrating vascular malformations and mechanotransduction by pharmacological intervention. J Clin Invest. 2022;132(8): e160227.","journal-title":"J Clin Invest"},{"issue":"12","key":"471_CR19","first-page":"1295","volume":"30","author":"S Kuroda","year":"2002","unstructured":"Kuroda S, Ishikawa T, Houkin K, Iwasaki Y. Clinical significance of posterior cerebral artery stenosis\/occlusion in moyamoya disease. No Shinkei Geka. 2002;30(12):1295\u2013300.","journal-title":"No Shinkei Geka"},{"issue":"1","key":"471_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1161\/STROKEAHA.111.621300","volume":"43","author":"L Duan","year":"2012","unstructured":"Duan L, Bao XY, Yang WZ, Shi WC, Li DS, Zhang ZS, et al. Moyamoya disease in China: its clinical features and outcomes. Stroke. 2012;43(1):56\u201360.","journal-title":"Stroke"},{"key":"471_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4103\/sni.sni_18_18","volume":"9","author":"A Ohkura","year":"2018","unstructured":"Ohkura A, Negoto T, Aoki T, Noguchi K, Okamoto Y, Komatani H, et al. Stenotic changes of the posterior cerebral artery are a major contributing factor for cerebral infarction in moyamoya disease. Surg Neurol Int. 2018;9:105.","journal-title":"Surg Neurol Int"},{"issue":"3","key":"471_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1161\/CIRCULATIONAHA.117.028021","volume":"137","author":"CA Emdin","year":"2018","unstructured":"Emdin CA, Khera AV, Klarin D, Natarajan P, Zekavat SM, Nomura A, et al. Phenotypic consequences of a genetic predisposition to enhanced nitric oxide signaling. Circulation. 2018;137(3):222\u201332.","journal-title":"Circulation"},{"issue":"7480","key":"471_CR23","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/nature12722","volume":"504","author":"J Erdmann","year":"2013","unstructured":"Erdmann J, Stark K, Esslinger UB, Rumpf PM, Koesling D, de Wit C, et al. Dysfunctional nitric oxide signalling increases risk of myocardial infarction. Nature. 2013;504(7480):432\u20136.","journal-title":"Nature"},{"key":"471_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.687088","volume":"12","author":"Y Mineharu","year":"2021","unstructured":"Mineharu Y, Miyamoto S. RNF213 and GUCY1A3 in moyamoya disease: key regulators of metabolism, inflammation, and vascular stability. Front Neurol. 2021;12: 687088.","journal-title":"Front Neurol"},{"key":"471_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.735416","volume":"11","author":"L Martina","year":"2021","unstructured":"Martina L, Asselman C, Thery F, Boucher K, Delhaye L, Maia TM, et al. Proteome profiling of RNF213 depleted cells reveals nitric oxide regulator DDAH1 antilisterial activity. Front Cell Infect Microbiol. 2021;11: 735416.","journal-title":"Front Cell Infect Microbiol"},{"issue":"77","key":"471_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.niox.2018.04.010","volume":"1","author":"LK Wareham","year":"2018","unstructured":"Wareham LK, Buys ES, Sappington RM. The nitric oxide-guanylate cyclase pathway and glaucoma. Nitric Oxide Biol Chem. 2018;1(77):75\u201387.","journal-title":"Nitric Oxide Biol Chem"},{"key":"471_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fnmol.2014.00038","volume":"7","author":"ES Buys","year":"2014","unstructured":"Buys ES, Potter LR, Pasquale LR, Ksander BR. Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucoma. Front Mol Neurosci. 2014;7:38.","journal-title":"Front Mol Neurosci"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-023-00471-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-023-00471-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-023-00471-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T20:56:18Z","timestamp":1679864178000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-023-00471-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,20]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["471"],"URL":"https:\/\/doi.org\/10.1186\/s40246-023-00471-x","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,20]]},"assertion":[{"value":"31 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All included probands and family members provided their written informed consent for genetic analysis as requested by the French law, and for publication of data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}